Abstract
The behavioral effects of 3β-(4-chlorophenyl)tropane-2β-carboxylic acid phenyl ester hydrochloride (RTI-113; 0.03–1.0 mg/kg), a selective dopamine uptake inhibitor, were compared with those of cocaine (0.03–3.0 mg/kg) and 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909; 0.03–3.0 mg/kg) in squirrel monkeys. Intermediate doses of each drug produced significant increases in response rate maintained by a fixed-interval (FI) 300-s schedule of stimulus termination, but RTI-113 was less effective than cocaine or GBR 12909. The order of potency for increasing response rate was RTI-113 ≥ cocaine > GBR 12909. In drug time course determinations, RTI-113 and GBR 12909 had longer durations of action than cocaine. RTI-113 substituted completely for cocaine in subjects trained to discriminate cocaine and saline under a two-lever drug-discrimination procedure maintained by food delivery. RTI-113 also reliably maintained self-administration behavior in subjects trained under a second-order FI 900-s schedule of i.v. cocaine delivery. Pretreatment with RTI-113 significantly decreased responding for cocaine at the highest pretreatment dose, but RTI-113 had similar effects on responding maintained by a second-order FI 900-s schedule of stimulus termination. The results indicate that the behavioral pharmacology of RTI-113 is similar to that of cocaine, further implicating a prominent role for dopamine uptake inhibition in the behavioral effects of cocaine. Its longer duration of action in conjunction with less pronounced behavioral-stimulant effects are desirable properties for a substitute pharmacotherapy for cocaine abuse. RTI-113 effectively decreased cocaine self-administration behavior, although its direct rate-altering effects may have contributed to the interactions obtained.
Footnotes
-
Send reprint requests to: Dr. Leonard L. Howell, Yerkes Regional Primate Research Center, Emory University, Atlanta, GA 30322. E-mail: leonard{at}rmy.emory.edu
-
↵1 This research was supported in part by U.S. Public Health Service Grants DA-01161, DA-05346, DA-10344, and RR-00165 (Division of Research Resources, National Institutes of Health) and Contract Grant OND-6069 (Office of National Drug Control Policy). The Yerkes Regional Primate Research Center is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International).
- Abbreviations:
- GBR 12909
- 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine dihydrochloride
- FI
- fixed interval
- FR
- fixed ratio
- RTI-113
- 3β-(4-chlorophenyl)tropane-2β-carboxylic acid phenyl ester hydrochloride
- Received March 23, 1999.
- Accepted October 13, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|